{"id":368653,"date":"2025-09-01T16:29:08","date_gmt":"2025-09-01T16:29:08","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/how-to-buy-cipla-limited\/"},"modified":"2025-09-11T06:29:17","modified_gmt":"2025-09-11T06:29:17","slug":"how-to-buy-cipla-limited","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cipla-limited\/","title":{"rendered":"How to buy Cipla Limited (CIPLA) shares &#8211; Investment in Cipla Limited (CIPLA) stock"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334018,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-368653","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"How to Buy Cipla Limited (CIPLA) Shares - Investment in Cipla Limited (CIPLA) Stock","h1_source":{"label":"H1","type":"text","formatted_value":"How to Buy Cipla Limited (CIPLA) Shares - Investment in Cipla Limited (CIPLA) Stock"},"description":"Learn how to buy Cipla Limited (CIPLA) shares with our comprehensive investment analysis. Discover current stock performance, risks, and growth potential for 2025-2030.","description_source":{"label":"Description","type":"textarea","formatted_value":"Learn how to buy Cipla Limited (CIPLA) shares with our comprehensive investment analysis. Discover current stock performance, risks, and growth potential for 2025-2030."},"intro":"Thinking about investing in India's pharmaceutical powerhouse? Cipla Limited represents stability meets growth in the booming healthcare sector. With over 80 years of experience and a presence in 80+ countries, this isn't just another pharma stock\u2014it's a gateway to the future of global medicine. Let's explore why Cipla deserves your attention and how you can become part of their growth story.","intro_source":{"label":"Intro","type":"text","formatted_value":"Thinking about investing in India's pharmaceutical powerhouse? Cipla Limited represents stability meets growth in the booming healthcare sector. With over 80 years of experience and a presence in 80+ countries, this isn't just another pharma stock\u2014it's a gateway to the future of global medicine. Let's explore why Cipla deserves your attention and how you can become part of their growth story."},"body_html":"<h2>\ud83d\udcc8 Cipla Stock: Current Price and Critical Dates<\/h2> <p>As of September 11, 2025, Cipla Limited (CIPLA) trades at <strong>\u20b91,563.80<\/strong> on the National Stock Exchange of India. This price reflects the company's strong Q1 2025 performance where they reported a 10% profit increase to \u20b91,298 crore and revenue growth to \u20b96,957 crore<a href=\"https:\/\/stockanalysis.com\/quote\/nse\/CIPLA\/\">Stock Analysis<\/a>.<\/p> <p><strong>Mark your calendar: November 5, 2025<\/strong> is absolutely critical for any Cipla investor. That's when the company releases its Q2 2026 earnings results. Historically, these quarterly reports have moved the stock significantly\u2014both up and down.<\/p> <h3>How Earnings Reports Impact CIPLA Stock<\/h3> <table> <thead> <tr><th>Date<\/th><th>Event<\/th><th>Pre-News Price<\/th><th>Post-News Change<\/th><\/tr> <\/thead> <tbody> <tr><td>May 13, 2025<\/td><td>Q4 2025 Earnings<\/td><td>\u20b91,520<\/td><td>+2.9% (beat estimates)<\/td><\/tr> <tr><td>Jan 28, 2025<\/td><td>Q3 2025 Earnings<\/td><td>\u20b91,480<\/td><td>+5.4% (strong US growth)<\/td><\/tr> <tr><td>Oct 29, 2024<\/td><td>Q2 2025 Earnings<\/td><td>\u20b91,420<\/td><td>+3.2% (market expansion)<\/td><\/tr> <tr><td>Jul 26, 2024<\/td><td>Q1 2025 Earnings<\/td><td>\u20b91,380<\/td><td>+4.1% (new product launches)<\/td><\/tr> <tr><td>May 10, 2024<\/td><td>Q4 2024 Earnings<\/td><td>\u20b91,335<\/td><td>+6.8% (record margins)<\/td><\/tr> <\/tbody> <\/table> <p><strong>Trend Insight<\/strong>: Cipla typically beats earnings expectations, with positive surprises driving 3-7% price jumps. The most dramatic move came after Q4 2024 results when the stock surged nearly 7% in a week.<\/p>  [cta_green text=\"Start trading\"]<h2>\ud83d\udcca 6-Month Price Journey and Trend Analysis<\/h2> <p>Cipla shares have shown remarkable resilience over the past six months, gaining <strong>7.97%<\/strong> despite broader market volatility<a href=\"https:\/\/stockanalysis.com\/quote\/nse\/CIPLA\/\">Stock Analysis<\/a>. Here's how the journey unfolded:<\/p> <table> <thead> <tr><th>Month<\/th><th>Price Range<\/th><th>Key Catalyst<\/th><\/tr> <\/thead> <tbody> <tr><td>March 2025<\/td><td>\u20b91,450-1,500<\/td><td>Post-earnings consolidation<\/td><\/tr> <tr><td>April 2025<\/td><td>\u20b91,480-1,520<\/td><td>Africa market expansion news<\/td><\/tr> <tr><td>May 2025<\/td><td>\u20b91,500-1,550<\/td><td>Strong Q4 results release<\/td><\/tr> <tr><td>June 2025<\/td><td>\u20b91,520-1,580<\/td><td>FDA facility approval news<\/td><\/tr> <tr><td>July 2025<\/td><td>\u20b91,560-1,600<\/td><td>Q1 2026 earnings beat<\/td><\/tr> <tr><td>August 2025<\/td><td>\u20b91,550-1,580<\/td><td>ESG rating concerns<\/td><\/tr> <\/tbody> <\/table> <p>The stock demonstrated particular strength in May and July following positive earnings surprises. However, August brought some pressure due to the ESG rating downgrade from B+ to B by SES ESG Research.<\/p> <p><strong>Technical Perspective<\/strong>: With a beta of 0.10<a href=\"https:\/\/stockanalysis.com\/quote\/nse\/CIPLA\/\">Stock Analysis<\/a>, Cipla shows low correlation to broader market movements, making it an excellent defensive play during market turbulence.<\/p>  <h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2> <p>Based on comprehensive analyst projections and machine learning models, here's what you can expect from Cipla shares:<\/p> <ul> <li><strong>2025 Year-End<\/strong>: \u20b91,660 - \u20b91,888 (4-22% upside potential)<\/li> <li><strong>2026 Projection<\/strong>: \u20b91,900 - \u20b92,310 (20-48% growth)<\/li> <li><strong>2028 Outlook<\/strong>: \u20b92,600 - \u20b93,462 (66-121% appreciation)<\/li> <li><strong>2030 Vision<\/strong>: \u20b93,500 - \u20b94,215 (126-172% total returns)<a href=\"https:\/\/dailybulls.in\/cipla-share-price-target-2024-to-2030\/\">Daily Bulls<\/a><\/strong><\/li> <\/ul> <p><strong>Verdict<\/strong>: STRONG BUY for long-term investors. The company's strategic positioning in respiratory therapeutics and emerging market expansion provides solid fundamentals for sustained growth.<\/p>  <h2>\u26a0\ufe0f Key Risks Every Investor Must Consider<\/h2> <h3>Regulatory Compliance Challenges<\/h3> <p>Cipla faces ongoing FDA scrutiny across multiple facilities. The Goa facility received a warning letter in November 2023, and while recent inspections show improvement (only one observation in January 2025), regulatory risks remain elevated<a href=\"https:\/\/images.moneycontrol.com\/static-mcnews\/2025\/01\/20250128091816_Investment-idea-Cipla.pdf\">Moneycontrol<\/a>.<\/p> <h3>ESG Rating Pressure<\/h3> <p>The recent downgrade from B+ to B by SES ESG Research primarily affected social and governance scores. While not catastrophic, this could limit access to ESG-focused investment funds<a href=\"https:\/\/scanx.trade\/stock-market-news\/stocks\/cipla-s-bommasandra-facility-receives-vai-classification-from-usfda\/15911262\">ScanX Trade<\/a>.<\/p> <h3>Margin Sustainability Concerns<\/h3> <p>Management has indicated that the current 28% EBITDA margin may be unsustainable long-term, suggesting potential margin compression ahead<a href=\"https:\/\/www.cnbctv18.com\/market\/cipla-share-price-q3-results-fy25-guidance-impact-from-pepfar-funding-freeze-19547776.htm\">CNBC TV18<\/a>.<\/p>  <h2>\ud83d\ude80 Positive Signals and Growth Catalysts<\/h2> <h3>Strategic Acquisitions and Partnerships<\/h3> <p>In August 2025, Cipla acquired a 20% voting stake in iCaltech Innovations, signaling strong commitment to technological innovation. The company also announced incremental investments in Achira Labs and expansion of its US joint venture with Kemwell Biopharma.<\/p> <h3>Product Innovation Leadership<\/h3> <p>Cipla launched HUENA\u00ae, India's first non-antibiotic treatment for recurring urinary tract infections\u2014a groundbreaking solution addressing antimicrobial resistance.<\/p> <h3>Geographic Diversification<\/h3> <p>North America delivered $221 million in quarterly revenue, while African markets grew 15% year-over-year. Emerging Markets and Europe posted impressive 16% growth<a href=\"https:\/\/www.cipla.com\/sites\/default\/files\/Cipla_Q4FY25%20Press%20Release_3.pdf\">Cipla Q4 Report<\/a>.<\/p>  <h2>\ud83d\udcf0 Significant News Impact Analysis (Last 6 Months)<\/h2> <h3>August 2025: Mixed Regulatory News<\/h3> <p>The Bommasandra facility received VAI (Voluntary Action Indicated) classification from USFDA\u2014a positive development indicating no official enforcement action needed. However, the ESG rating downgrade created some investor concern.<\/p> <h3>July 2025: Strong Quarterly Results<\/h3> <p>Q1 2026 earnings showed 10% profit growth to \u20b91,298 crore, driven by robust performance in India and African markets. The \"One India\" business crossed \u20b93,000 crores for the first time in any quarter.<\/p> <h3>Strategic Partnerships Expansion<\/h3> <p>Cipla entered multiple licensing agreements, including a non-exclusive patent license with Takeda for Vonoprazan commercialization in India and a distribution agreement with Sanofi to expand CNS portfolio reach.<\/p>  <h2>\ud83c\udfaf What Should a Beginner Trader Do Today?<\/h2> <p><strong>Serious Recommendations:<\/strong><\/p> <ol> <li><strong>Start small with systematic investing<\/strong> - Use dollar-cost averaging with monthly investments rather than timing the market<\/li> <li><strong>Set price alerts around \u20b91,520-1,540<\/strong> - These levels have provided strong support during recent corrections<\/li> <li><strong>Monitor November 5th earnings closely<\/strong> - Consider adding positions if the stock dips post-earnings<\/li> <\/ol> <p><strong>Humorous veteran advice:<\/strong> \"Trading Cipla is like taking medicine\u2014sometimes it tastes bitter short-term, but it's good for your portfolio's health long-term. Just don't try to day-trade it like candy!\"<\/p>  <h2>\u2705 How to Buy Cipla Limited (CIPLA) Shares - Step by Step<\/h2> <table> <thead> <tr><th>Step<\/th><th>Action<\/th><th>Why It Matters<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Choose a trading platform<\/td><td>Ensure it offers access to NSE (National Stock Exchange of India)<\/td><\/tr> <tr><td>2<\/td><td>Complete KYC verification<\/td><td>Submit required documents for regulatory compliance<\/td><\/tr> <tr><td>3<\/td><td>Fund your trading account<\/td><td>Start with an amount you're comfortable risking<\/td><\/tr> <tr><td>4<\/td><td>Search for \"CIPLA\"<\/td><td>Use the exact ticker symbol for accurate results<\/td><\/tr> <tr><td>5<\/td><td>Place a limit order<\/td><td>Set your maximum purchase price to avoid overpaying<\/td><\/tr> <tr><td>6<\/td><td>Monitor your investment<\/td><td>Track performance through quarterly results and news<\/td><\/tr> <\/tbody> <\/table> <p><strong>Pro Tip<\/strong>: Always use limit orders rather than market orders when buying Indian stocks to maintain control over your entry price.<\/p>  <h2>\ud83d\udca1 Why Pocket Option Makes Sense for New Investors<\/h2> <p>For those beginning their investment journey, Pocket Option offers several advantages that align perfectly with Cipla's long-term growth story:<\/p> <ul> <li><strong>Minimum deposit of just $5<\/strong> allows you to test strategies with minimal risk while building confidence in pharmaceutical sector investing.<\/li> <li><strong>Rapid KYC process<\/strong> requiring only one document means you can start trading within minutes rather than days\u2014crucial for catching timely opportunities around earnings announcements.<\/li> <li><strong>Diverse withdrawal options<\/strong> including multiple cryptocurrencies, e-wallets, and traditional banking methods provide flexibility as your investment grows.<\/li> <\/ul> <p>The platform's user-friendly interface makes monitoring Cipla's performance straightforward, with real-time charts and news integration helping you make informed decisions about when to add to your position.<\/p>  <h2>\ud83c\udf0d Cipla in 2025: India's Pharmaceutical Beacon<\/h2> <p>Cipla Limited stands as India's third-largest pharmaceutical company with approximately 5.4% market share domestically<a href=\"https:\/\/dcfmodeling.com\/products\/ciplans-business-model-canvas\">DCF Modeling<\/a>. The company's business model spans healthcare professionals, hospitals, clinics, and over 60,000 pharmacies across India.<\/p> <p>Beyond traditional pharmaceuticals, Cipla has built a massive consumer business exceeding \u20b91,000 crore with five brands each generating over \u20b9100 crore annually. Their retail vertical engages with over 150,000 stores nationwide<a href=\"https:\/\/images.moneycontrol.com\/static-mcnews\/2025\/01\/20250128091816_Investment-idea-Cipla.pdf\">Moneycontrol<\/a>.<\/p> <p><strong>Interesting Fact from 2025<\/strong>: Cipla launched a unique 100-day campaign called \"Saksham Niveshak\" in August 2025 specifically focused on investor engagement and awareness\u2014demonstrating their commitment to transparent shareholder communication even during market uncertainties.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Cipla Stock: Current Price and Critical Dates<\/h2>\n<p>As of September 11, 2025, Cipla Limited (CIPLA) trades at <strong>\u20b91,563.80<\/strong> on the National Stock Exchange of India. This price reflects the company&#8217;s strong Q1 2025 performance where they reported a 10% profit increase to \u20b91,298 crore and revenue growth to \u20b96,957 crore<a href=\"https:\/\/stockanalysis.com\/quote\/nse\/CIPLA\/\">Stock Analysis<\/a>.<\/p>\n<p><strong>Mark your calendar: November 5, 2025<\/strong> is absolutely critical for any Cipla investor. That&#8217;s when the company releases its Q2 2026 earnings results. Historically, these quarterly reports have moved the stock significantly\u2014both up and down.<\/p>\n<h3>How Earnings Reports Impact CIPLA Stock<\/h3>\n<table>\n<thead>\n<tr>\n<th>Date<\/th>\n<th>Event<\/th>\n<th>Pre-News Price<\/th>\n<th>Post-News Change<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>May 13, 2025<\/td>\n<td>Q4 2025 Earnings<\/td>\n<td>\u20b91,520<\/td>\n<td>+2.9% (beat estimates)<\/td>\n<\/tr>\n<tr>\n<td>Jan 28, 2025<\/td>\n<td>Q3 2025 Earnings<\/td>\n<td>\u20b91,480<\/td>\n<td>+5.4% (strong US growth)<\/td>\n<\/tr>\n<tr>\n<td>Oct 29, 2024<\/td>\n<td>Q2 2025 Earnings<\/td>\n<td>\u20b91,420<\/td>\n<td>+3.2% (market expansion)<\/td>\n<\/tr>\n<tr>\n<td>Jul 26, 2024<\/td>\n<td>Q1 2025 Earnings<\/td>\n<td>\u20b91,380<\/td>\n<td>+4.1% (new product launches)<\/td>\n<\/tr>\n<tr>\n<td>May 10, 2024<\/td>\n<td>Q4 2024 Earnings<\/td>\n<td>\u20b91,335<\/td>\n<td>+6.8% (record margins)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Trend Insight<\/strong>: Cipla typically beats earnings expectations, with positive surprises driving 3-7% price jumps. The most dramatic move came after Q4 2024 results when the stock surged nearly 7% in a week.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/en\/register\/\" class=\"po-cta-green\">Start trading\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6-Month Price Journey and Trend Analysis<\/h2>\n<p>Cipla shares have shown remarkable resilience over the past six months, gaining <strong>7.97%<\/strong> despite broader market volatility<a href=\"https:\/\/stockanalysis.com\/quote\/nse\/CIPLA\/\">Stock Analysis<\/a>. Here&#8217;s how the journey unfolded:<\/p>\n<table>\n<thead>\n<tr>\n<th>Month<\/th>\n<th>Price Range<\/th>\n<th>Key Catalyst<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>March 2025<\/td>\n<td>\u20b91,450-1,500<\/td>\n<td>Post-earnings consolidation<\/td>\n<\/tr>\n<tr>\n<td>April 2025<\/td>\n<td>\u20b91,480-1,520<\/td>\n<td>Africa market expansion news<\/td>\n<\/tr>\n<tr>\n<td>May 2025<\/td>\n<td>\u20b91,500-1,550<\/td>\n<td>Strong Q4 results release<\/td>\n<\/tr>\n<tr>\n<td>June 2025<\/td>\n<td>\u20b91,520-1,580<\/td>\n<td>FDA facility approval news<\/td>\n<\/tr>\n<tr>\n<td>July 2025<\/td>\n<td>\u20b91,560-1,600<\/td>\n<td>Q1 2026 earnings beat<\/td>\n<\/tr>\n<tr>\n<td>August 2025<\/td>\n<td>\u20b91,550-1,580<\/td>\n<td>ESG rating concerns<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The stock demonstrated particular strength in May and July following positive earnings surprises. However, August brought some pressure due to the ESG rating downgrade from B+ to B by SES ESG Research.<\/p>\n<p><strong>Technical Perspective<\/strong>: With a beta of 0.10<a href=\"https:\/\/stockanalysis.com\/quote\/nse\/CIPLA\/\">Stock Analysis<\/a>, Cipla shows low correlation to broader market movements, making it an excellent defensive play during market turbulence.<\/p>\n<h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2>\n<p>Based on comprehensive analyst projections and machine learning models, here&#8217;s what you can expect from Cipla shares:<\/p>\n<ul>\n<li><strong>2025 Year-End<\/strong>: \u20b91,660 &#8211; \u20b91,888 (4-22% upside potential)<\/li>\n<li><strong>2026 Projection<\/strong>: \u20b91,900 &#8211; \u20b92,310 (20-48% growth)<\/li>\n<li><strong>2028 Outlook<\/strong>: \u20b92,600 &#8211; \u20b93,462 (66-121% appreciation)<\/li>\n<li><strong>2030 Vision<\/strong>: \u20b93,500 &#8211; \u20b94,215 (126-172% total returns)<a href=\"https:\/\/dailybulls.in\/cipla-share-price-target-2024-to-2030\/\">Daily Bulls<\/a><\/strong><\/li>\n<\/ul>\n<p><strong>Verdict<\/strong>: STRONG BUY for long-term investors. The company&#8217;s strategic positioning in respiratory therapeutics and emerging market expansion provides solid fundamentals for sustained growth.<\/p>\n<h2>\u26a0\ufe0f Key Risks Every Investor Must Consider<\/h2>\n<h3>Regulatory Compliance Challenges<\/h3>\n<p>Cipla faces ongoing FDA scrutiny across multiple facilities. The Goa facility received a warning letter in November 2023, and while recent inspections show improvement (only one observation in January 2025), regulatory risks remain elevated<a href=\"https:\/\/images.moneycontrol.com\/static-mcnews\/2025\/01\/20250128091816_Investment-idea-Cipla.pdf\">Moneycontrol<\/a>.<\/p>\n<h3>ESG Rating Pressure<\/h3>\n<p>The recent downgrade from B+ to B by SES ESG Research primarily affected social and governance scores. While not catastrophic, this could limit access to ESG-focused investment funds<a href=\"https:\/\/scanx.trade\/stock-market-news\/stocks\/cipla-s-bommasandra-facility-receives-vai-classification-from-usfda\/15911262\">ScanX Trade<\/a>.<\/p>\n<h3>Margin Sustainability Concerns<\/h3>\n<p>Management has indicated that the current 28% EBITDA margin may be unsustainable long-term, suggesting potential margin compression ahead<a href=\"https:\/\/www.cnbctv18.com\/market\/cipla-share-price-q3-results-fy25-guidance-impact-from-pepfar-funding-freeze-19547776.htm\">CNBC TV18<\/a>.<\/p>\n<h2>\ud83d\ude80 Positive Signals and Growth Catalysts<\/h2>\n<h3>Strategic Acquisitions and Partnerships<\/h3>\n<p>In August 2025, Cipla acquired a 20% voting stake in iCaltech Innovations, signaling strong commitment to technological innovation. The company also announced incremental investments in Achira Labs and expansion of its US joint venture with Kemwell Biopharma.<\/p>\n<h3>Product Innovation Leadership<\/h3>\n<p>Cipla launched HUENA\u00ae, India&#8217;s first non-antibiotic treatment for recurring urinary tract infections\u2014a groundbreaking solution addressing antimicrobial resistance.<\/p>\n<h3>Geographic Diversification<\/h3>\n<p>North America delivered $221 million in quarterly revenue, while African markets grew 15% year-over-year. Emerging Markets and Europe posted impressive 16% growth<a href=\"https:\/\/www.cipla.com\/sites\/default\/files\/Cipla_Q4FY25%20Press%20Release_3.pdf\">Cipla Q4 Report<\/a>.<\/p>\n<h2>\ud83d\udcf0 Significant News Impact Analysis (Last 6 Months)<\/h2>\n<h3>August 2025: Mixed Regulatory News<\/h3>\n<p>The Bommasandra facility received VAI (Voluntary Action Indicated) classification from USFDA\u2014a positive development indicating no official enforcement action needed. However, the ESG rating downgrade created some investor concern.<\/p>\n<h3>July 2025: Strong Quarterly Results<\/h3>\n<p>Q1 2026 earnings showed 10% profit growth to \u20b91,298 crore, driven by robust performance in India and African markets. The &#8220;One India&#8221; business crossed \u20b93,000 crores for the first time in any quarter.<\/p>\n<h3>Strategic Partnerships Expansion<\/h3>\n<p>Cipla entered multiple licensing agreements, including a non-exclusive patent license with Takeda for Vonoprazan commercialization in India and a distribution agreement with Sanofi to expand CNS portfolio reach.<\/p>\n<h2>\ud83c\udfaf What Should a Beginner Trader Do Today?<\/h2>\n<p><strong>Serious Recommendations:<\/strong><\/p>\n<ol>\n<li><strong>Start small with systematic investing<\/strong> &#8211; Use dollar-cost averaging with monthly investments rather than timing the market<\/li>\n<li><strong>Set price alerts around \u20b91,520-1,540<\/strong> &#8211; These levels have provided strong support during recent corrections<\/li>\n<li><strong>Monitor November 5th earnings closely<\/strong> &#8211; Consider adding positions if the stock dips post-earnings<\/li>\n<\/ol>\n<p><strong>Humorous veteran advice:<\/strong> &#8220;Trading Cipla is like taking medicine\u2014sometimes it tastes bitter short-term, but it&#8217;s good for your portfolio&#8217;s health long-term. Just don&#8217;t try to day-trade it like candy!&#8221;<\/p>\n<h2>\u2705 How to Buy Cipla Limited (CIPLA) Shares &#8211; Step by Step<\/h2>\n<table>\n<thead>\n<tr>\n<th>Step<\/th>\n<th>Action<\/th>\n<th>Why It Matters<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Choose a trading platform<\/td>\n<td>Ensure it offers access to NSE (National Stock Exchange of India)<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Complete KYC verification<\/td>\n<td>Submit required documents for regulatory compliance<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Fund your trading account<\/td>\n<td>Start with an amount you&#8217;re comfortable risking<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Search for &#8220;CIPLA&#8221;<\/td>\n<td>Use the exact ticker symbol for accurate results<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Place a limit order<\/td>\n<td>Set your maximum purchase price to avoid overpaying<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Monitor your investment<\/td>\n<td>Track performance through quarterly results and news<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Pro Tip<\/strong>: Always use limit orders rather than market orders when buying Indian stocks to maintain control over your entry price.<\/p>\n<h2>\ud83d\udca1 Why Pocket Option Makes Sense for New Investors<\/h2>\n<p>For those beginning their investment journey, Pocket Option offers several advantages that align perfectly with Cipla&#8217;s long-term growth story:<\/p>\n<ul>\n<li><strong>Minimum deposit of just $5<\/strong> allows you to test strategies with minimal risk while building confidence in pharmaceutical sector investing.<\/li>\n<li><strong>Rapid KYC process<\/strong> requiring only one document means you can start trading within minutes rather than days\u2014crucial for catching timely opportunities around earnings announcements.<\/li>\n<li><strong>Diverse withdrawal options<\/strong> including multiple cryptocurrencies, e-wallets, and traditional banking methods provide flexibility as your investment grows.<\/li>\n<\/ul>\n<p>The platform&#8217;s user-friendly interface makes monitoring Cipla&#8217;s performance straightforward, with real-time charts and news integration helping you make informed decisions about when to add to your position.<\/p>\n<h2>\ud83c\udf0d Cipla in 2025: India&#8217;s Pharmaceutical Beacon<\/h2>\n<p>Cipla Limited stands as India&#8217;s third-largest pharmaceutical company with approximately 5.4% market share domestically<a href=\"https:\/\/dcfmodeling.com\/products\/ciplans-business-model-canvas\">DCF Modeling<\/a>. The company&#8217;s business model spans healthcare professionals, hospitals, clinics, and over 60,000 pharmacies across India.<\/p>\n<p>Beyond traditional pharmaceuticals, Cipla has built a massive consumer business exceeding \u20b91,000 crore with five brands each generating over \u20b9100 crore annually. Their retail vertical engages with over 150,000 stores nationwide<a href=\"https:\/\/images.moneycontrol.com\/static-mcnews\/2025\/01\/20250128091816_Investment-idea-Cipla.pdf\">Moneycontrol<\/a>.<\/p>\n<p><strong>Interesting Fact from 2025<\/strong>: Cipla launched a unique 100-day campaign called &#8220;Saksham Niveshak&#8221; in August 2025 specifically focused on investor engagement and awareness\u2014demonstrating their commitment to transparent shareholder communication even during market uncertainties.<\/p>\n"},"faq":[{"question":"What is the minimum investment required to buy Cipla shares?","answer":"There's no minimum share requirement\u2014you can purchase even one share. However, consider transaction costs; investing at least \u20b95,000-10,000 makes economic sense after brokerage fees."},{"question":"How often does Cipla pay dividends?","answer":"Cipla typically pays dividends annually. The company has maintained a consistent dividend payout history, making it attractive for income-seeking investors."},{"question":"Is Cipla affected by currency exchange rates?","answer":"Yes, significantly. Since Cipla generates about 68% of revenue internationally<a href=\"https:\/\/www.cnbctv18.com\/market\/cipla-share-price-q3-results-fy25-guidance-impact-from-pepfar-funding-freeze-19547776.htm\">CNBC TV18<\/a>, rupee-dollar exchange rates directly impact financial results."},{"question":"What are Cipla's main competitive advantages?","answer":"Key advantages include dominance in respiratory therapeutics, strong emerging market presence, robust R&D spending (6-8% of revenue), and extensive distribution network across 80+ countries."},{"question":"How volatile is Cipla stock compared to the broader market?","answer":"With a beta of 0.10<a href=\"https:\/\/stockanalysis.com\/quote\/nse\/CIPLA\/\">Stock Analysis<\/a>, Cipla is significantly less volatile than the overall market, making it a relatively stable pharmaceutical investment."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"What is the minimum investment required to buy Cipla shares?","answer":"There's no minimum share requirement\u2014you can purchase even one share. However, consider transaction costs; investing at least \u20b95,000-10,000 makes economic sense after brokerage fees."},{"question":"How often does Cipla pay dividends?","answer":"Cipla typically pays dividends annually. The company has maintained a consistent dividend payout history, making it attractive for income-seeking investors."},{"question":"Is Cipla affected by currency exchange rates?","answer":"Yes, significantly. Since Cipla generates about 68% of revenue internationally<a href=\"https:\/\/www.cnbctv18.com\/market\/cipla-share-price-q3-results-fy25-guidance-impact-from-pepfar-funding-freeze-19547776.htm\">CNBC TV18<\/a>, rupee-dollar exchange rates directly impact financial results."},{"question":"What are Cipla's main competitive advantages?","answer":"Key advantages include dominance in respiratory therapeutics, strong emerging market presence, robust R&D spending (6-8% of revenue), and extensive distribution network across 80+ countries."},{"question":"How volatile is Cipla stock compared to the broader market?","answer":"With a beta of 0.10<a href=\"https:\/\/stockanalysis.com\/quote\/nse\/CIPLA\/\">Stock Analysis<\/a>, Cipla is significantly less volatile than the overall market, making it a relatively stable pharmaceutical investment."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>How to buy Cipla Limited (CIPLA) shares - Investment in Cipla Limited (CIPLA) stock<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cipla-limited\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to buy Cipla Limited (CIPLA) shares - Investment in Cipla Limited (CIPLA) stock\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cipla-limited\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-01T16:29:08+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-11T06:29:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1408\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cipla-limited\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cipla-limited\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"How to buy Cipla Limited (CIPLA) shares &#8211; Investment in Cipla Limited (CIPLA) stock\",\"datePublished\":\"2025-09-01T16:29:08+00:00\",\"dateModified\":\"2025-09-11T06:29:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cipla-limited\/\"},\"wordCount\":15,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cipla-limited\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cipla-limited\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cipla-limited\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cipla-limited\/\",\"name\":\"How to buy Cipla Limited (CIPLA) shares - Investment in Cipla Limited (CIPLA) stock\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cipla-limited\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cipla-limited\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"datePublished\":\"2025-09-01T16:29:08+00:00\",\"dateModified\":\"2025-09-11T06:29:17+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cipla-limited\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cipla-limited\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cipla-limited\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cipla-limited\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How to buy Cipla Limited (CIPLA) shares &#8211; Investment in Cipla Limited (CIPLA) stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How to buy Cipla Limited (CIPLA) shares - Investment in Cipla Limited (CIPLA) stock","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cipla-limited\/","og_locale":"en_US","og_type":"article","og_title":"How to buy Cipla Limited (CIPLA) shares - Investment in Cipla Limited (CIPLA) stock","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cipla-limited\/","og_site_name":"Pocket Option blog","article_published_time":"2025-09-01T16:29:08+00:00","article_modified_time":"2025-09-11T06:29:17+00:00","og_image":[{"width":1408,"height":768,"url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp","type":"image\/webp"}],"author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cipla-limited\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cipla-limited\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"How to buy Cipla Limited (CIPLA) shares &#8211; Investment in Cipla Limited (CIPLA) stock","datePublished":"2025-09-01T16:29:08+00:00","dateModified":"2025-09-11T06:29:17+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cipla-limited\/"},"wordCount":15,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cipla-limited\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cipla-limited\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cipla-limited\/","url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cipla-limited\/","name":"How to buy Cipla Limited (CIPLA) shares - Investment in Cipla Limited (CIPLA) stock","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cipla-limited\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cipla-limited\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","datePublished":"2025-09-01T16:29:08+00:00","dateModified":"2025-09-11T06:29:17+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cipla-limited\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cipla-limited\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cipla-limited\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-cipla-limited\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/en\/"},{"@type":"ListItem","position":2,"name":"How to buy Cipla Limited (CIPLA) shares &#8211; Investment in Cipla Limited (CIPLA) stock"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/en\/#website","url":"https:\/\/pocketoption.com\/blog\/en\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":368771,"slug":"how-to-buy-cipla-limited","post_title":"Comment acheter des actions Cipla Limited (CIPLA) - Investissement dans les actions Cipla Limited (CIPLA)","href":"https:\/\/pocketoption.com\/blog\/fr\/news-events\/signal\/how-to-buy-cipla-limited\/"},"it_IT":{"locale":"it_IT","id":368768,"slug":"how-to-buy-cipla-limited","post_title":"Come acquistare azioni Cipla Limited (CIPLA) - Investire in azioni Cipla Limited (CIPLA)","href":"https:\/\/pocketoption.com\/blog\/it\/news-events\/signal\/how-to-buy-cipla-limited\/"},"pl_PL":{"locale":"pl_PL","id":368766,"slug":"how-to-buy-cipla-limited","post_title":"Jak kupi\u0107 akcje Cipla Limited (CIPLA) - Inwestycja w akcje Cipla Limited (CIPLA)","href":"https:\/\/pocketoption.com\/blog\/pl\/news-events\/signal\/how-to-buy-cipla-limited\/"},"es_ES":{"locale":"es_ES","id":368769,"slug":"how-to-buy-cipla-limited","post_title":"C\u00f3mo comprar acciones de Cipla Limited (CIPLA) - Inversi\u00f3n en acciones de Cipla Limited (CIPLA)","href":"https:\/\/pocketoption.com\/blog\/es\/news-events\/signal\/how-to-buy-cipla-limited\/"},"th_TH":{"locale":"th_TH","id":368767,"slug":"how-to-buy-cipla-limited","post_title":"\u0e27\u0e34\u0e18\u0e35\u0e0b\u0e37\u0e49\u0e2d\u0e2b\u0e38\u0e49\u0e19 Cipla Limited (CIPLA) - \u0e01\u0e32\u0e23\u0e25\u0e07\u0e17\u0e38\u0e19\u0e43\u0e19\u0e2b\u0e38\u0e49\u0e19 Cipla Limited (CIPLA)","href":"https:\/\/pocketoption.com\/blog\/th\/news-events\/signal\/how-to-buy-cipla-limited\/"},"tr_TR":{"locale":"tr_TR","id":368772,"slug":"how-to-buy-cipla-limited","post_title":"Cipla Limited (CIPLA) Hisseleri Nas\u0131l Al\u0131n\u0131r - Cipla Limited (CIPLA) Hisse Senedi Yat\u0131r\u0131m\u0131","href":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-cipla-limited\/"},"vt_VT":{"locale":"vt_VT","id":368770,"slug":"how-to-buy-cipla-limited","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Cipla Limited (CIPLA) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Cipla Limited (CIPLA)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-cipla-limited\/"},"pt_AA":{"locale":"pt_AA","id":368765,"slug":"how-to-buy-cipla-limited","post_title":"Como comprar a\u00e7\u00f5es da Cipla Limited (CIPLA) - Investimento em a\u00e7\u00f5es da Cipla Limited (CIPLA)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-cipla-limited\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/368653","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/comments?post=368653"}],"version-history":[{"count":1,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/368653\/revisions"}],"predecessor-version":[{"id":373013,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/368653\/revisions\/373013"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media\/334018"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media?parent=368653"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/categories?post=368653"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/tags?post=368653"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}